Literature DB >> 4977045

Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.

E Atlas, H Clark, F Silverblatt, M Turck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4977045     DOI: 10.7326/0003-4819-70-4-713

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  14 in total

1.  In vitro evaluation of a new quinolone antibacterial.

Authors:  G Stilwell; K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1975-04       Impact factor: 5.191

2.  In vitro activity of cinoxacin, an organic acid antibacterial.

Authors:  S Kurtz; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

3.  In vitro susceptibility comparisons and recommendations for oxolinic acid.

Authors:  D Klein; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

4.  Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.

Authors:  P M Gilis; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

5.  Factors governing the emergence of resistance to nalidixic acid in treatment of urinary tract infection.

Authors:  D Greenwood; F O'Grady
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

6.  Effect of derivatives of 3-quinolinecarboxylic acid on DNA synthesis, growth and division in Escherichia coli 15 TAU.

Authors:  V Sulcová; J Hanová; A Capek; V Vondrejs
Journal:  Folia Microbiol (Praha)       Date:  1974       Impact factor: 2.099

7.  Bactericidal effect of combinations of nalidixic acid and various antibiotics on Enterobacteriaceae.

Authors:  J Michel; R Luboshitzky; T Sacks
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

8.  The place of quinolones in antibacterial therapy in hospitals.

Authors:  R P Mouton
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

9.  Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.

Authors:  A Bertolini; M Castelli; S Genedani; M Garuti
Journal:  Experientia       Date:  1980-02-15

10.  Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.

Authors:  D Greenwood
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.